Conversely, over-expression of IRF4 in CLL seems to interfere with survival signals mediated by BCR activation and leukemic cell homing inside “proliferation centers”, counteracting key signals of CLL progression and clonal evolution. Here, BCR is linked to B-cell chronic lymphocytic leukemia.